Evogene | EVGN - Ebitda


Evogene reported $-2.95M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
CVR Partners USD 77.72M 7.11M Mar/2026
Evogene USD -2.95M 2M Mar/2026
Globe Specialty Metals USD 14.59M 3.68M Dec/2025
Hawkins USD 35.97M 11.96M Dec/2025
Innospec USD 43.7M 12M Mar/2026
Intrepid Potash USD 6.85M 119K Sep/2024
Koppers USD 42.3M 10.9M Mar/2026
Kronos Worldwide USD 28.9M 86.8M Mar/2026
LSB Industries USD 54.08M 13.98M Dec/2025
Materion USD 52.9M 4.1M Mar/2026
Minerals Technologies USD 92.9M 5.6M Mar/2026
Rayonier Advanced Materials USD -31.78M 77.78M Mar/2026
Sensient Technologies USD 86.04M 23.01M Mar/2026
Stepan USD 49.6M 15.8M Mar/2026
Tronox USD 62M 5M Mar/2026
Valhi USD 45.7M 21.3M Mar/2026
WD-40 USD 28.66M 3.3M Dec/2025